Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive factors of achieving therapeutic goals of hypertriglyceridemia.
Pintó X, Valdivielso P, Perez de Juan JM, Plana N, Garcia-Arias C, Fuentes FJ, Hernández-Mijares A, Mostaza JM; Spanish Registry of Hypertriglyceridemia (Spanish Society of Arteriosclerosis, SAS). Pintó X, et al. Curr Med Res Opin. 2014 Jan;30(1):19-26. doi: 10.1185/03007995.2013.850069. Epub 2013 Oct 18. Curr Med Res Opin. 2014. PMID: 24083660
Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects.
Hernández-Mijares A, Ascaso JF, Blasco M, Brea Á, Díaz Á, Mantilla T, Pedro-Botet J, Pintó X, Millán J; Grupo de trabajo sobre Dislipidemia Aterogénica, Sociedad Española de Arteriosclerosis. Hernández-Mijares A, et al. Clin Investig Arterioscler. 2019 Mar-Apr;31(2):75-88. doi: 10.1016/j.arteri.2018.06.007. Epub 2018 Sep 24. Clin Investig Arterioscler. 2019. PMID: 30262442 Review. English, Spanish.
[Fibrates therapy: Rational use fenofibrate 2016. Executive summary].
Brea A, Millán J, Ascaso JF, Blasco M, Díaz A, González-Santos P, Hernández-Mijares A, Mantilla T, Pedro-Botet JC, Pintó X; en nombre del Foro de la Dislipemia Aterogénica. Brea A, et al. Clin Investig Arterioscler. 2016 Nov-Dec;28(6):295-301. doi: 10.1016/j.arteri.2016.06.001. Epub 2016 Sep 5. Clin Investig Arterioscler. 2016. PMID: 27609708 Spanish.
[The real measurement of non-HDL-cholesterol: Atherogenic cholesterol].
Millán J, Hernández-Mijares A, Ascaso JF, Blasco M, Brea A, Díaz Á, González-Santos P, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis. Millán J, et al. Clin Investig Arterioscler. 2016 Nov-Dec;28(6):265-270. doi: 10.1016/j.arteri.2016.05.002. Epub 2016 Sep 12. Clin Investig Arterioscler. 2016. PMID: 27633523 Spanish.
Non-HDL cholesterol as a therapeutic goal.
Brea A, Hernández-Mijares A, Millán J, Ascaso JF, Blasco M, Díaz A, Mantilla T, Pedro-Botet JC, Pintó X. Brea A, et al. Clin Investig Arterioscler. 2019 Dec;31 Suppl 2:28-33. doi: 10.1016/j.arteri.2019.07.002. Epub 2019 Dec 2. Clin Investig Arterioscler. 2019. PMID: 31806265 English, Spanish.
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias.
Pedro-Botet J, Ascaso JF, Blasco M, Brea Á, Díaz Á, Hernández-Mijares A, Pintó X, Millán J; Grupo de trabajo sobre Dislipidemia Aterogénica, Sociedad Española de Arteriosclerosis. Pedro-Botet J, et al. Clin Investig Arterioscler. 2020 Sep-Oct;32(5):209-218. doi: 10.1016/j.arteri.2019.12.003. Epub 2020 Feb 6. Clin Investig Arterioscler. 2020. PMID: 32037300 English, Spanish.
Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study.
Fernández-Cidón B, Candás-Estébanez B, Gil-Serret M, Amigó N, Corbella E, Rodríguez-Sánchez MÁ, Padró-Miquel A, Brotons C, Hernández-Mijares A, Calmarza P, Jarauta E, Brea AJ, Mauri M, Guijarro C, Vila À, Valdivielso P, Corbella X, Pintó X. Fernández-Cidón B, et al. Among authors: hernandez mijares a. J Clin Med. 2021 Mar 29;10(7):1379. doi: 10.3390/jcm10071379. J Clin Med. 2021. PMID: 33805580 Free PMC article.
[The role of atherogenic dyslipidaemia in clinical practice guidelines].
Pedro-Botet J, Mantilla-Morató T, Díaz-Rodríguez Á, Brea-Hernando Á, González-Santos P, Hernández-Mijares A, Pintó X, Millán Núñez-Cortés J. Pedro-Botet J, et al. Clin Investig Arterioscler. 2016 Mar-Apr;28(2):65-70. doi: 10.1016/j.arteri.2015.12.004. Epub 2016 Mar 2. Clin Investig Arterioscler. 2016. PMID: 26949069 Spanish.
201 results